Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-28

Clinical Trial Update: Amniotic Membrane Treatment for Hyposecretory Dry Eye [Phase 3]

View source ↗

Summary

Phase 3 trial investigating amniotic membrane treatment for hyposecretory dry eye has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amniotic membrane treatment

Snippet

Sponsor: Hospital Nacional Profesor Alejandro Posadas | Conditions: Dry Eye Syndromes, Sjogren Syndrome With Keratoconjunctivitis | Phase 3 | Status: COMPLETED